Clinical Trial Update: A Phase 3 Substudy to Evaluate Executive Function in Adults With PKU Who Are Participating in the Phase 3 Study, 165-302

View source ↗

Summary

Phase 3 substudy assessing executive function in adults with phenylketonuria participating in the main Phase 3 trial has completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Phenylketonuria | Status: COMPLETED | Results posted: 2020-06-04